FURTHER RESEARCH DIRECTIONS

Research on probiotics in poultry continues to offer substantial opportunities, particularly in strain-specific immunomodulation [210]. Future studies should focus on defining immune signatures, cytokine patterns, mucosal IgA, T cell polarization, and vaccine-associated antibody kinetics, to move beyond generalized efficacy claims. Multi-omics approaches (metagenomics, transcriptomics, metabolomics) can clarify interactions between probiotics, gut microbiota, and the avian immune system, revealing molecular pathways that influence gut health [303].

Beyond classical immune endpoints, probiotics may also modulate stress and behavior via the gut–brain axis. Evidence shows reductions in H/L ratios and corticosterone levels under heat or management stress, suggesting benefits for welfare, resilience, and performance. Integrating behavioral assays, stress biomarkers, and microbiome profiling can elucidate neuroimmune mechanisms in poultry [135].

Innovative strategies include recombinant probiotics and early-life interventions. Engineered strains can produce targeted bioactive molecules to enhance immunity and vaccination responses [304]. Early post-hatch supplementation may shape long-term gut–immune development and disease resilience. Complementary approaches like postbiotics and paraprobiotics, non-viable microbial components or metabolites, offer advantages in stability, safety, and precise dosing [305]. Comparative field studies are needed to evaluate efficacy, stability, cost-effectiveness, and regulatory feasibility of live probiotics, synbiotics, and non-viable alternatives [306].

Sustainability and One Health outcomes warrant attention. Probiotics may improve nutrient utilization, reduce ammonia emissions, and lower pathogen loads in litter, potentially mitigating environmental contamination and AMR. Life-cycle assessments and longitudinal farm-scale evaluations are needed to quantify these benefits [307].

Breed-specific and local strains represent another priority. Tailoring probiotics to genetic and physiological differences may optimize immune responses and microbiota colonization, while locally adapted strains can improve viability, safety, and cost-effectiveness [308].

Figure 4[303–310] illustrates the “Precision Probiotic Pyramid” as a conceptual framework for poultry health management. The base of the pyramid represents conventional single-strain probiotics, the middle layer includes synbiotics, postbiotics, and multi-strain formulations, while the apex integrates precision-designed probiotics guided by artificial intelligence, multi-omics approaches, and breed-specific data to maximize efficacy under stress or disease challenge conditions. Future innovations may involve engineered probiotics, targeted metabolite delivery, and predictive AI modeling, validated through large-scale, multi-site field trials.

From an industry perspective, priorities include scalable production, feed stability, cost–benefit validation, and integration with vaccination and antimicrobial stewardship [309]. From a research perspective, focus areas include reproducible trials, standardized immune biomarkers, precision dosing, and mechanistic validation of strain-specific effects to strengthen translational reliability [310].

Figure 4: Precision Probiotic Pyramid for poultry health management. This schematic illustration was conceptually developed based on published evidence [303–310] and generated using artificial intelligence tools (ChatGPT 5.2), then subsequently modified by the authors.